Quick Takeaways
  • Trial production of XPENG P7+ marks manufacturing readiness for Europe.
  • Localized assembly at an established European facility supports quality and regulatory compliance ahead of market entry.
On January 8, XPENG confirmed that trial production of the updated XPENG P7+ has been successfully completed at its manufacturing facility in Austria, marking a key milestone ahead of the model’s planned European market entry. This development highlights the company’s growing focus on strengthening its production footprint and readiness for Europe.
The new XPENG P7+ will be assembled at Magna’s Graz facility in Austria, where two other XPENG models are already in production. Leveraging this established manufacturing base is expected to support consistent build quality, efficient processes, and a smoother transition into large-scale production for the European market.
XPENG P7+ Production Strategy for Europe
The XPENG P7+ represents the company’s next step in expanding its sedan portfolio for Europe. By utilizing the Graz facility, XPENG benefits from existing production expertise and localized assembly capabilities that align with regional quality standards and regulatory expectations.
Key aspects of the production approach include:
  • Use of an established European manufacturing site
  • Integration with existing XPENG production lines
  • Focus on meeting European quality and compliance requirements

Ongoing R&D and Manufacturing Readiness
Alongside trial production, XPENG is advancing into the next phase of research and development and production validation. These efforts are aimed at ensuring the XPENG P7+ meets performance, reliability, and quality benchmarks before customer deliveries begin.
The company noted that continued refinement of production processes and technical validation will play a critical role in achieving a high-quality launch across European markets, reinforcing XPENG’s long-term commitment to the region.
Company Social Media Page

Click above to visit the official source.

Share: